“At the moment, in addition to Remdesivir, which has shown itself in reducing hospitalizations, but not mortality, there are no other encouraging antiviral drugs,” RIA Novosti quoted her as saying at a briefing by the Association of Foreign Correspondents at the UN Geneva office.
In late April, the Russian Ministry of Health expanded the list of possible drugs against coronavirus infection.
Among the drugs that are at the stage of clinical trials, umifenovir, remdesivir, favipiravir are noted.